Market closed
SI-BONE/$SIBN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About SI-BONE
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Ticker
$SIBN
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
349
Website
SI-BONE Metrics
BasicAdvanced
$611M
-
-$0.75
1.02
-
Price and volume
Market cap
$611M
Beta
1.02
52-week high
$19.16
52-week low
$11.70
Average daily volume
342K
Financial strength
Current ratio
7.658
Quick ratio
6.553
Long term debt to equity
21.76
Total debt to equity
22.45
Interest coverage (TTM)
-10.25%
Management effectiveness
Return on assets (TTM)
-9.56%
Return on equity (TTM)
-18.38%
Valuation
Price to revenue (TTM)
3.569
Price to book
3.63
Price to tangible book (TTM)
3.63
Price to free cash flow (TTM)
-26.032
Growth
Revenue change (TTM)
20.37%
Earnings per share change (TTM)
-33.50%
3-year revenue growth (CAGR)
22.86%
3-year earnings per share growth (CAGR)
-23.97%
What the Analysts think about SI-BONE
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for SI-BONE stock.
SI-BONE Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
SI-BONE Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
SI-BONE News
AllArticlesVideos
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance
GlobeNewsWire·2 months ago
Bruker Appoints Laura Francis to its Board of Directors
Business Wire·2 months ago
SI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025
GlobeNewsWire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for SI-BONE stock?
SI-BONE (SIBN) has a market cap of $611M as of April 26, 2025.
What is the P/E ratio for SI-BONE stock?
The price to earnings (P/E) ratio for SI-BONE (SIBN) stock is 0 as of April 26, 2025.
Does SI-BONE stock pay dividends?
No, SI-BONE (SIBN) stock does not pay dividends to its shareholders as of April 26, 2025.
When is the next SI-BONE dividend payment date?
SI-BONE (SIBN) stock does not pay dividends to its shareholders.
What is the beta indicator for SI-BONE?
SI-BONE (SIBN) has a beta rating of 1.02. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.